These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20655910)

  • 41. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
    Samadi P; Grégoire L; Morissette M; Calon F; Hadj Tahar A; Bélanger N; Dridi M; Bédard PJ; Di Paolo T
    Neuropharmacology; 2008 Feb; 54(2):258-68. PubMed ID: 18001807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A(2A) receptor antagonist.
    Barodia SK; Mishra CB; Prakash A; Senthil Kumar JB; Kumari N; Luthra PM
    Neurosci Lett; 2011 Jan; 488(1):1-5. PubMed ID: 20708066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purinergic signaling in Parkinson's disease. Relevance for treatment.
    Navarro G; Borroto-Escuela DO; Fuxe K; Franco R
    Neuropharmacology; 2016 May; 104():161-8. PubMed ID: 26211977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.
    Szabó N; Kincses ZT; Vécsei L
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):441-55. PubMed ID: 21332415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.
    Riahi G; Morissette M; Parent M; Di Paolo T
    Eur J Neurosci; 2011 May; 33(10):1823-31. PubMed ID: 21501255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.
    Pinna A
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1619-31. PubMed ID: 19888872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
    Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.
    Jastrzębska J; Nowak E; Smaga I; Bystrowska B; Frankowska M; Bader M; Filip M; Fuxe K
    Neuropharmacology; 2014 Jun; 81():318-26. PubMed ID: 24632528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.
    Shook BC; Rassnick S; Osborne MC; Davis S; Westover L; Boulet J; Hall D; Rupert KC; Heintzelman GR; Hansen K; Chakravarty D; Bullington JL; Russell R; Branum S; Wells KM; Damon S; Youells S; Li X; Beauchamp DA; Palmer D; Reyes M; Demarest K; Tang Y; Rhodes K; Jackson PF
    J Med Chem; 2010 Nov; 53(22):8104-15. PubMed ID: 20973483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys.
    Kanda T; Jackson MJ; Smith LA; Pearce RK; Nakamura J; Kase H; Kuwana Y; Jenner P
    Ann Neurol; 1998 Apr; 43(4):507-13. PubMed ID: 9546333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms.
    Yu L; Shen HY; Coelho JE; Araújo IM; Huang QY; Day YJ; Rebola N; Canas PM; Rapp EK; Ferrara J; Taylor D; Müller CE; Linden J; Cunha RA; Chen JF
    Ann Neurol; 2008 Mar; 63(3):338-46. PubMed ID: 18300283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders.
    Müller CE; Ferré S
    Recent Pat CNS Drug Discov; 2007 Jan; 2(1):1-21. PubMed ID: 18221214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease.
    Weiss SM; Benwell K; Cliffe IA; Gillespie RJ; Knight AR; Lerpiniere J; Misra A; Pratt RM; Revell D; Upton R; Dourish CT
    Neurology; 2003 Dec; 61(11 Suppl 6):S101-6. PubMed ID: 14663021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Corticostriatal Adenosine A
    Li Z; Chen X; Wang T; Gao Y; Li F; Chen L; Xue J; He Y; Li Y; Guo W; Zheng W; Zhang L; Ye F; Ren X; Feng Y; Chan P; Chen JF
    Biol Psychiatry; 2018 Mar; 83(6):530-541. PubMed ID: 28941549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
    Neustadt BR; Liu H; Hao J; Greenlee WJ; Stamford AW; Foster C; Arik L; Lachowicz J; Zhang H; Bertorelli R; Fredduzzi S; Varty G; Cohen-Williams M; Ng K
    Bioorg Med Chem Lett; 2009 Feb; 19(3):967-71. PubMed ID: 19109019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348.
    Grauer SM; Hodgson R; Hyde LA
    Psychopharmacology (Berl); 2014 Apr; 231(7):1325-37. PubMed ID: 24150248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
    Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
    Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission.
    Quiroz C; Pearson V; Gulyani S; Allen R; Earley C; Ferré S
    Exp Neurol; 2010 Jul; 224(1):292-8. PubMed ID: 20385128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.